-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Versigent, Raises Price Target to $58

Benzinga·08/05/2026 19:28:00
语音播报
TD Cowen analyst Itay Michaeli maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $49 to $58.